Safety and efficacy of BIOSYNSORB immunoadsorption column treatment.
Sakhrani
L M
LM
National Institute of Transplantation, Los Angeles, California 90057.
Minasian
R
R
Aswad
S
S
Obispo
E
E
Mendez
R
R
Mendez
R G
RG
D000017:ABO Blood-Group System / Q000276:immunology*; D001323:Autoantibodies / Q000302:isolation & purification*; D001787:Blood Group Incompatibility; D006464:Hemoperfusion / Q000295:instrumentation / Q000379:methods*; D006801:Humans; D007075:Immunoglobulin M / Q000097:blood* / Q000302:isolation & purification; D007163:Immunosorbent Techniques; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016030:Kidney Transplantation / Q000276:immunology / Q000502:physiology*; D016896:Treatment Outcome
D000017:ABO Blood-Group System; D001323:Autoantibodies; D007075:Immunoglobulin M; D007166:Immunosuppressive Agents